Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK-Reference-Cited by-同舟云学术

Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK

Published:2021-12-06 Issue:1 Volume:60 Page:25-37
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

ALTamimi Jozaa Z.¹^ORCID,Alshammari Ghedeir M.²^ORCID,AlFaris Nora A.¹^ORCID,Alagal Reham I.¹^ORCID,Aljabryn Dalal H.¹^ORCID,Albekairi Norah A.³,Alkhateeb Mahmoud Ahmad⁴,Yahya Mohammed Abdo²^ORCID

Affiliation:

1. Nutrition and Food Science, Department of Physical Sport Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

2. Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia

3. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

4. Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia

Funder

the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2021.1990969

Reference92 articles.

1. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy

2. Advanced glycation endproducts—role in pathology of diabetic complications

3. Ellagic acid protects against diabetic nephropathy in rats by regulating the transcription and activity of Nrf2

4. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling and Optimization of Ellagic Acid from Chebulae Fructus Using Response Surface Methodology Coupled with Artificial Neural Network;Molecules;2024-08-21

2. Exploring the molecular mechanisms underlying neuroprotective effect of ellagic acid in okadaic acid-induced Alzheimer’s phenotype;Metabolic Brain Disease;2024-08-12

3. Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds;Heliyon;2024-08

4. Targeting AMPK related signaling pathways: A feasible approach for natural herbal medicines to intervene non-alcoholic fatty liver disease;Journal of Pharmaceutical Analysis;2024-08

5. Ellagic acid as potential therapeutic compound for diabetes and its complications: a systematic review from bench to bed;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-09